» Articles » PMID: 20581410

Asthma and Allergy Patterns over 18 Years After Severe RSV Bronchiolitis in the First Year of Life

Overview
Journal Thorax
Date 2010 Jun 29
PMID 20581410
Citations 309
Authors
Affiliations
Soon will be listed here.
Abstract

Background: An increased prevalence of asthma/recurrent wheeze (RW), clinical allergy and allergic sensitisation up to age 13 years has previously been reported in subjects hospitalised with respiratory syncytial virus (RSV) bronchiolitis in their first year of life compared with matched controls. A study was undertaken to examine whether these features persist into early adulthood, to report longitudinal wheeze and allergy patterns, and to see how large and small airway function relates to RSV infection and asthma.

Methods: Follow-up at age 18 years was performed in 46 of 47 subjects with RSV and 92 of 93 controls. Assessments included questionnaire, clinical examination, skin prick tests, serum IgE antibodies to inhaled allergens, blood eosinophils, fraction of exhaled nitric oxide (FeNO), spirometry, multiple breath washout (lung clearance index, LCI) and dry air hyperventilation challenge.

Results: Increased prevalence of asthma/RW (39% vs 9%), clinical allergy (43% vs 17%) and sensitisation to perennial allergens (41% vs 14%) were present at age 18 in the RSV cohort compared with controls. Persistent/relapsing wheeze associated with early allergic sensitisation predominated in the RSV cohort compared with controls (30% vs 1%). Spirometric function was reduced in subjects with RSV with or without current asthma, but not in asthmatic controls. LCI was linked only to current asthma, airway hyperresponsiveness and FeNO.

Conclusions: Severe early RSV bronchiolitis is associated with an increased prevalence of allergic asthma persisting into early adulthood. Small airway dysfunction (LCI) is related to current asthma and airway inflammation but not to RSV bronchiolitis. Reduced spirometry after RSV may reflect airway remodelling.

Citing Articles

Harnessing Epigenetics: Innovative Approaches in Diagnosing and Combating Viral Acute Respiratory Infections.

Saha A, Ganguly A, Kumar A, Srivastava N, Pathak R Pathogens. 2025; 14(2).

PMID: 40005506 PMC: 11858160. DOI: 10.3390/pathogens14020129.


Repeated and alternate stimulations with dsRNA and SEB alter responses in macrophages and epithelial cells.

Choi J, Kim Y, Kim M, Kang M, Hwang Y, Yoon J World Allergy Organ J. 2025; 18(2):101026.

PMID: 39925983 PMC: 11804812. DOI: 10.1016/j.waojou.2025.101026.


Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy.

Marcellusi A, Bini C, Muzii B, Soudani S, Kieffer A, Beuvelet M Glob Reg Health Technol Assess. 2025; 12:16-28.

PMID: 39897385 PMC: 11783691. DOI: 10.33393/grhta.2025.3182.


Coumarins and Hesperetin Inhibit Human Respiratory Syncytial Virus Infection.

de Sa J, Thongpan I, Busso J, Rodrigues T, Chen P, Helena A Int J Mol Sci. 2025; 25(24.

PMID: 39769063 PMC: 11676883. DOI: 10.3390/ijms252413301.


The Interplay Between Respiratory Syncytial Virus and Asthma Inception: Insights Gained From the COVID-19 Pandemic.

Amram T, Duek O, Golan-Tripto I, Goldbart A, Greenberg D, Hazan G Pediatr Pulmonol. 2025; 60(1):e27474.

PMID: 39760467 PMC: 11748096. DOI: 10.1002/ppul.27474.